Laboratory of Food Chemistry, Wageningen University, P.O. Box 17, 6700 AA Wageningen, The Netherlands.
Department of Developmental Psychology, Behavioral Science Institute, Radboud University, P.O. Box 9104, 6500 HE Nijmegen, The Netherlands.
J Agric Food Chem. 2021 Jun 9;69(22):6186-6199. doi: 10.1021/acs.jafc.0c07484. Epub 2021 May 25.
To follow human milk oligosaccharide (HMO) biosynthesis and in vivometabolization, mother milk and infant feces from 68 mother-infant dyads at 2, 6, and 12 weeks postpartum were analyzed, with 18 major HMOs quantitated. Fucosylated and neutral core HMO levels in milk were dependent on mothers' Lewis/Secretor status, whereas most sialylated HMO levels were independent. Infant fecal excretion of HMOs gradually declined with age, especially for neutral core structures. Although decreasing in absolute concentrations in milk during lactation, the relative abundance of total fucosylated HMOs increased in both milk and feces. Mono-fucosylated HMOs were more consumed than those decorated with two fucose moieties. More (α2-3)-sialylated HMOs were degraded than (α2-6)-sialylated HMOs. The transition speed of HMO metabolization from nonspecific or structure-specific consumption stage to the complete consumption stage was individual-dependent. Variation was associated with mode and place of delivery, where caesarean section or early exposure to hospital environment delayed the transition.
为了跟踪人乳寡糖(HMO)的生物合成和体内代谢,我们分析了 68 对母婴在产后 2、6 和 12 周的母乳和婴儿粪便,定量了 18 种主要的 HMO。母乳中糖基化和中性核心 HMO 的水平取决于母亲的 Lewis/Secretor 状态,而大多数唾液酸化 HMO 的水平是独立的。婴儿粪便中 HMO 的排泄量随年龄逐渐下降,尤其是中性核心结构。尽管在哺乳期母乳中 HMO 的绝对浓度下降,但总糖基化 HMO 的相对丰度在母乳和粪便中均增加。单糖基化 HMO 的消耗多于双糖基化 HMO。(α2-3)-唾液酸化 HMO 的降解多于(α2-6)-唾液酸化 HMO。HMO 代谢从非特异性或结构特异性消耗阶段向完全消耗阶段的转变速度取决于个体。这种变化与分娩方式和地点有关,剖宫产或早期暴露于医院环境会延迟这种转变。